Antibody–Oligonucleotide Conjugates Clinical Manufacturing — A New Paradigm Shift of Bio-Conjugates for Therapeutics
Experience.
History-Making.
BIO International 2026: Twenty Years After FDA’s Exploratory IND Guidance: Is the Time Finally Right for Exploratory Development of Therapeutic Antibodies and Recombinant Proteins?
What’s the Buzz?! Episode Recording
What’s the Buzz?! | BioFlorida and the Regenerative Medicine Bloom
GBI Biomanufacturing Appoints Chandra Kelley as Chief Business Officer
‘Demand is growing:’ Plantation lab ramps up stem-cell production
Longtime biotech company expands Broward County facility
Stem Cell Opportunities Expand-and so does GBI
‘Right to Try’ Laws Place Stem Cells Front and Center in Regenerative Pain Medicine
